Adult Dosing
Prevention of motion sickness
- 1 patch behind ear q3 days prn; apply at least 4hrs before travel
Prevention of post-op nausea/vomiting
- Apply 1 patch behind ear evening before surgery or 1hr before cesarean section
Note: 1 patch releases 1 mg of scopolamine over 3 days.
Pediatric Dosing
- Safety and effectiveness in pediatric patients have not been established
[Outline]
See Supplemental Patient Information
- Monitor glaucoma therapy in patients with chronic open-angle glaucoma, adjust dose during use of scopolamine as mydriatic effect may increase intraocular pressure
- Prohibit use in children
- Rare idiosyncratic reactions have occurred even with ordinary therapeutic doses of scopolamine
- Skin burns have occurred in patients wearing an aluminized transdermal systems during a magnetic resonance imaging scan, remove the system before undergoing an MRI
- Bradycardia, hypotension, muscle weakness, equililbrium disturbance have occurred on discontinuing
- Interferes with the gastric secretion test
- Increase risk in elderly of CNS effects, elevated intraocular pressure, urinary retention, constipation
- Potential aggravation of psychosis with history
- Pyloric obstruction
Use cautiously in:
- Renal impairment
- History of seizures
- Hepatic impairment
- Cardiac disease
- Arrhythmias
- Pyloric obstruction
- Urinary bladder neck obstruction
- Intestinal obstruction
- History of psychosis
- Open angle glaucoma
- Hyperthyroidism
- Pulmonary disease
- Autonomic neuropathy
- Use of anticholinergic
- Geriatrics
Supplemental Patient Information
- Caution patients about engaging in activities requiring mental alertness like driving a motor vehicle or operating dangerous machinery as drowsiness, disorientation and confusion may occur
Pregnancy Category:C
Breastfeeding: Safety unknown; information is unavailable on the use of scopolamine during breastfeeding. Prolong use of drug results in reduction of milk production or milk letdown. A single systemic or ophthalmic dose is unlikely to interfere with breastfeeding. On prolong use observe for signs of decreased lactation such as insatiety and poor weight gain. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. This drug is compatible and considered safe with breastfeeding based upon data from AAP Policy Guidelines (available at http://aappolicy.aappublications.org/cgi/content/full/pediatrics;108/3/776/T6 last accessed 24 November 2010). Manufacturer advises caution while using in nursing women
Pricing data from www.DrugStore.com in U.S.A.
- Transderm-Scop 1.5 MG PT72 [Box] (NOVARTIS)
4 mg = $55.99
8 mg = $105.97
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.
